Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  369 results for ""CARDIAC hypertrophy""

Your Filters

Publication : british journal of pharmacology
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.

  • Source: British Journal of Pharmacology. Jun2015, Vol. 172 Issue 11, p2852-2863. 12p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy.

  • Source: British Journal of Pharmacology. May2015, Vol. 172 Issue 10, p2618-2633. 16p. 4 Charts, 7 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy.

  • Source: British Journal of Pharmacology. Sep2022, Vol. 179 Issue 18, p4516-4533. 18p. 5 Color Photographs, 2 Black and White Photographs, 1 Diagram.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Elevated mean arterial pressure in the ovariectomized rat was normalized by ET[subA] receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis.

  • Source: British Journal of Pharmacology. Jul2002, Vol. 136 Issue 5, p685-692. 8p. 3 Diagrams, 4 Charts.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway.

  • Source: British Journal of Pharmacology. May2016, Vol. 173 Issue 9, p1502-1516. 15p. 1 Diagram, 1 Chart, 7 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure.

  • Source: British Journal of Pharmacology. Jan2016, Vol. 173 Issue 1, p3-14. 12p. 4 Diagrams, 1 Chart, 1 Graph.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.

  • Source: British Journal of Pharmacology. Apr2013, Vol. 168 Issue 8, p1794-1807. 14p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function.

  • Source: British Journal of Pharmacology. Dec2015, Vol. 172 Issue 23, p5548-5558. 11p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy.

  • Source: British Journal of Pharmacology. Dec2013, Vol. 170 Issue 7, p1384-1395. 12p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Knockout of β1- and β2-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.

  • Source: British Journal of Pharmacology. Feb2008, Vol. 153 Issue 4, p684-692. 9p. 2 Charts, 5 Graphs.

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  369 results for ""CARDIAC hypertrophy""